ClinicalTrials.govpublic full text
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients
hepatitis, hepatitis c, hepatitis c/ human immunodeficiency virus coinfection, cepeginterferon alfa, peginterferon, treatment, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 884636
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.